KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zimmer Biomet Holdings (ZBH) Non-Current Assets (2016 - 2025)

Zimmer Biomet Holdings (ZBH) has 17 years of Non-Current Assets data on record, last reported at $18.0 billion in Q4 2025.

  • For Q4 2025, Non-Current Assets rose 7.66% year-over-year to $18.0 billion; the TTM value through Dec 2025 reached $70.0 billion, up 4.13%, while the annual FY2025 figure was $18.0 billion, 7.66% up from the prior year.
  • Non-Current Assets reached $18.0 billion in Q4 2025 per ZBH's latest filing, up from $17.7 billion in the prior quarter.
  • Across five years, Non-Current Assets topped out at $19.0 billion in Q1 2021 and bottomed at $16.6 billion in Q1 2025.
  • Average Non-Current Assets over 5 years is $17.4 billion, with a median of $16.9 billion recorded in 2023.
  • Peak YoY movement for Non-Current Assets: fell 10.41% in 2022, then rose 7.66% in 2025.
  • A 5-year view of Non-Current Assets shows it stood at $18.6 billion in 2021, then dropped by 10.41% to $16.6 billion in 2022, then rose by 1.49% to $16.9 billion in 2023, then fell by 1.15% to $16.7 billion in 2024, then grew by 7.66% to $18.0 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Non-Current Assets were $18.0 billion in Q4 2025, $17.7 billion in Q3 2025, and $17.8 billion in Q2 2025.